147 related articles for article (PubMed ID: 16087328)
21. Contemporary clinical management of isolated high-grade prostatic intraepithelial neoplasia.
Godoy G; Taneja SS
Prostate Cancer Prostatic Dis; 2008; 11(1):20-31. PubMed ID: 17909565
[TBL] [Abstract][Full Text] [Related]
22. Karyometry of secretory cell nuclei in high-grade PIN lesions.
Bartels PH; Montironi RM; Bostwick D; Marshall J; Thompson D; Bartels HG; Kelley D
Prostate; 2001 Aug; 48(3):144-55. PubMed ID: 11494330
[TBL] [Abstract][Full Text] [Related]
23. Properties of intraepithelial neoplasia relevant to the development of cancer chemopreventive agents.
Boone CW; Bacus JW; Bacus JV; Steele VE; Kelloff GJ
J Cell Biochem Suppl; 1997; 28-29():1-20. PubMed ID: 9589346
[TBL] [Abstract][Full Text] [Related]
24. Early development of cancer chemoprevention clinical trials: studies of dietary calcium as a chemopreventive agent for human subjects.
Lipkin M
Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S65-70. PubMed ID: 12570337
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms in Barrett's metaplasia and its progression.
Izzo JG; Luthra R; Wu TT; Correa AM; Luthra M; Anandasabapathy S; Chao KS; Hung MC; Aggarwal B; Hittelman WN; Ajani JA
Semin Oncol; 2007 Apr; 34(2 Suppl 1):S2-6. PubMed ID: 17449347
[TBL] [Abstract][Full Text] [Related]
26. Development of cancer chemopreventive drugs based on mechanistic approaches.
Steele VE; Kelloff GJ
Mutat Res; 2005 Dec; 591(1-2):16-23. PubMed ID: 16083917
[TBL] [Abstract][Full Text] [Related]
27. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population.
Plummer M; Vivas J; Lopez G; Bravo JC; Peraza S; Carillo E; Cano E; Castro D; Andrade O; Sánchez V; Garcia R; Buiatti E; Aebischer C; Franceschi S; Oliver W; Muñoz N
J Natl Cancer Inst; 2007 Jan; 99(2):137-46. PubMed ID: 17227997
[TBL] [Abstract][Full Text] [Related]
28. Finasteride as a chemopreventive agent in prostate cancer: impact of the PCPT on urologic practice.
Goetzl MA; Holzbeierlein JM
Nat Clin Pract Urol; 2006 Aug; 3(8):422-9. PubMed ID: 16902518
[TBL] [Abstract][Full Text] [Related]
29. Chemoprevention for prostatic intraepithelial neoplasia.
Nelson PS; Gleason TP; Brawer MK
Eur Urol; 1996; 30(2):269-78. PubMed ID: 8875211
[TBL] [Abstract][Full Text] [Related]
30. Molecular risk assessment for breast cancer development in patients with ductal hyperplasias.
Poola I; Abraham J; Marshalleck JJ; Yue Q; Lokeshwar VB; Bonney G; Dewitty RL
Clin Cancer Res; 2008 Feb; 14(4):1274-80. PubMed ID: 18281563
[TBL] [Abstract][Full Text] [Related]
31. Chemoprevention of adenocarcinoma associated with Barrett's esophagus: potential options.
Neumann H; Mönkemüller K; Vieth M; Malfertheiner P
Dig Dis; 2009; 27(1):18-23. PubMed ID: 19439956
[TBL] [Abstract][Full Text] [Related]
32. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
33. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
Tavora F; Epstein JI
Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
[TBL] [Abstract][Full Text] [Related]
34. Data representation and reduction for chromatin texture in nuclei from premalignant prostatic, esophageal, and colonic lesions.
Weyn B; Jacob W; da Silva VD; Montironi R; Hamilton PW; Thompson D; Bartels HG; Van Daele A; Dillon K; Bartels PH
Cytometry; 2000 Oct; 41(2):133-8. PubMed ID: 11002269
[TBL] [Abstract][Full Text] [Related]
35. Chemopreventive agent-induced modulation of death receptors.
Sun SY
Apoptosis; 2005 Dec; 10(6):1203-10. PubMed ID: 16215675
[TBL] [Abstract][Full Text] [Related]
36. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
[TBL] [Abstract][Full Text] [Related]
37. Karyometry of the colonic mucosa.
Alberts DS; Einspahr JG; Krouse RS; Prasad A; Ranger-Moore J; Hamilton P; Ismail A; Lance P; Goldschmid S; Hess LM; Yozwiak M; Bartels HG; Bartels PH
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2704-16. PubMed ID: 18086777
[TBL] [Abstract][Full Text] [Related]
38. The use of PSA as biomarker in nutritional intervention studies of prostate cancer.
van Weerden WM; Schröder FH
Chem Biol Interact; 2008 Jan; 171(2):204-11. PubMed ID: 18177847
[TBL] [Abstract][Full Text] [Related]
39. Strategies for identification and clinical evaluation of promising chemopreventive agents.
Kelloff GJ; Hawk ET; Crowell JA; Boone CW; Nayfield SG; Perloff M; Steele VE; Lubet RA
Oncology (Williston Park); 1996 Oct; 10(10):1471-84; discussion 1484-8. PubMed ID: 8905841
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of high-grade prostatic intraepithelial neoplasia (HGPIN): risk of prostatic cancer on repeat biopsies.
Gallo F; Chiono L; Gastaldi E; Venturino E; Giberti C
Urology; 2008 Sep; 72(3):628-32. PubMed ID: 18279918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
